DOH updates guidelines on COVID-19 vaccination

Robie de Guzman   •   April 16, 2021   •   241

MANILA, Philippines — The Department of Health (DOH) has revised its guidelines on the government’s COVID-19 vaccination and deployment program.

Under the Department Memorandum No. 2021-0175, the DOH said that individuals who recently recovered from COVID-19 may be vaccinated immediately after recovery or completion of treatment for their first or second dose.

The DOH previously said that persons who tested positive for COVID-19 had to wait for 90 days before they get vaccinated.

This development comes after the country’s vaccine experts panel recommended inoculating COVID-19 survivors 14 days after their recovery.

The new DOH guidelines also state that individuals who were not able to receive their second dose due to medical reasons must coordinate with their respective vaccination sites for the immediate rescheduling of their vaccination.

The agency also said that only individuals experiencing a blood pressure (BP) of 180/120 or higher, with signs and symptoms of organ damage during the screening process, cannot be vaccinated.

“Other vaccine recipients with blood pressure not meeting definitions of hypertensive emergency may be vaccinated,” the DOH said.

The department also emphasized that medical clearance is not required for vaccination, except for individuals with autoimmune disease, HIV, cancer patients currently undergoing immunosuppressive therapy, transplant patients, those undergoing steroid treatment, and patients who are bedridden or with a poor prognosis.

The national government is currently vaccinating persons and workers belonging to A1 (healthcare workers), A2 (senior citizens), and A3 (persons with comorbidities) priority sectors. The Inter-Agency Task Force has also approved the list of sectors that are included in the A4 group.

The DOH earlier reported that over one million Filipinos have been vaccinated against COVID-19 disease.

The agency, however, reminded to continue observing minimum public health standards even after vaccination to curb the transmission of COVID-19.

IATF places Cagayan, Apayao, Benguet back to MECQ due to high COVID-19 cases

Aileen Cerrudo   •   May 11, 2021

MANILA, Philippines—Northern provinces Cagayan, Apayao, and Benguet have reverted to modified enhanced community quarantine (MECQ) after recording high cases of coronavirus disease (COVID-19).

The MECQ status will take effect on May 11 until May 23.

As of May 10, Cagayan has 4,657 cases followed by Benguet with 531 and Apayao with 63.

Business operations in the said areas will be limited according to the directive of the Inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID).

A liquor ban will be implemented while religious gatherings will only be allowed at 10% capacity.  Entertainment and recreational events also be suspended.

Benguet governor Melchor Diclas reported that majority of the COVID-19 cases in their area are severe. Hospitals in Benguet are also in short supply of respirators.

“Dumadami talaga ang mga pasyente natin. Marami ang namamatay at marami ang nagkakasakit ng critical at serious. Ang respirator natin may nagagamit tayong 13 na respirator. Ang bakante nalang ay dalawa,” he said.

(Our patients are increasing. Many have died and many are in critical or serious condition. We have 13 respirators but there are only two available units left.)

Hospitals in Apayao, meanwhile, are at 80% critical level.  In Cagayan Province, Governor Manuel Mamba said Tuguegarao City’s home quarantine setup is still contributing to the rising cases of COVID-19.

“Hindi magiging epektibo ang MECQ sa Tuguegarao City hangga’t may home quarantine,” he said.

(MECQ in Tuguegarao City will not be effective as long as home quarantine is being implemented .)

Mamba continues to reiterate the need to build isolation facilities in Tuguegarao to accommodate COVID-19 patients. AAC (With reports from Marvin Calas)

 

 

Evaluation of EUA application for Sinopharm vax may be completed in less than 21 days – FDA

Robie de Guzman   •   May 11, 2021

MANILA, Philippines – The evaluation process for the Sinopharm COVID-19 vaccine will not take long before it can be granted an emergency use authorization (EUA) in the Philippines, the Food and Drug Administration (FDA) said Tuesday.

FDA director-general Eric Domingo said the Sinopharm vaccine has already been included in the emergency use listing (EUL) of the World Health Organization (WHO) and access to its documents, including inspection reports from the WHO will be faster.

“Useful yung kanyang Emergency Use Listing sa WHO kasi before this, wala pa siyang EUA from a stringent regulatory authority katulad ng mga USFDA ganyan or Europe, Japan… hindi pa siya listed sa mga iyon. Pero yung WHO na emergency use listing that’s equivalent to a stringent regulatory authority,” he said.

“Ang maganda sa WHO kasi very transparent ang documents nyan. Available din siya sa FDA. Lahat ng ni-review nila, maaari naming ma-access kaya hindi tayo masyado mahihirapan sa paghingi ng information,” he added.

The Department of Health (DOH) earlier said it has started the process of applying for EUA, pending documents about the vaccine product.

The FDA said the process may take less than 21 days once the DOH completes the application process.

“Kapag ganyan na merong WHO EUL, mas mapapabilis iyan. Nakakaya natin iyan usually less than 21 days,” Domingo said.

The FDA also echoed the DOH’s earlier statement that there are no irregularities with the government’s move to file an EUA for a Chinese-made vaccine since they also applied for the EUA of other COVID-19 vaccine brands, such as Sinovac, AstraZeneca, and Pfizer, in order for these vaccines to be delivered to the country.

“Talagang nasa batas and it’s a worldwide practice,” he said. “Based on WHO guidelines, posible naman na gobyerno gusto bumili ng bakuna na walang local manufacturer or representative dito. In those cases, the government itself can get EUA.”

“Hindi naman conflict yun dahil ang EUA ay hindi naman product registration o marketing authorization lang, talagang for emergency use lang ang mga bakuna,” he added. – RRD (with details from Correspondent Aiko Miguel)

Palace welcomes WHO’s emergency use listing for Sinopharm COVID-19 vaccine

Robie de Guzman   •   May 11, 2021

MANILA, Philippines – Malacañang on Tuesday welcomed the decision of the World Health Organization (WHO) to approve Sinopharm’s COVID-19 vaccine for emergency use listing (EUL).

In a statement, Presidential Spokesperson Harry Roque said this development will strengthen the country’s vaccine portfolio.

“We welcome the Emergency Use Listing (EUL) of the World Health Organization for Sinopharm. This development would strengthen our diversified vaccine portfolio as we continue to work on improving access to safe and effective vaccines, including Sinopharm,” Roque said.

A WHO emergency listing means that a product’s safety and efficacy has been rigorously evaluated. It will also allow the product to be included in the COVAX facility for faster global roll out.

The COVAX facility led by the WHO is a global program that seeks to provide vaccine supply mainly for poor countries.

The emergency use listing will also allow countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.

The Philippines has so far received more than 7.5 million doses of COVID-19 vaccines and more are expected to arrive in the next few weeks.

“With the arrival of the bulk of our vaccine orders in the coming months, we are confident that we would be able to speed up our coronavirus vaccination program,” Roque said.

The Department of Health earlier said the emergency use authorization (EUA) application for Sinopharm vaccine is now being processed.

The Food and Drug Administration said the application’s evaluation will not take long as the product is already under the WHO emergency use listing.

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.